CNS Flashcards
What are histologic features of astrocytic tumors?
Grade 2: nuclear atypia only
Grade 3: nuclear atypia, focal or dispersed anaplasia, increased mitotic activity
Grade 4: microvascular proliferation, necrosis (and nuclear atypia, increased mitoses, but only the first two are pathognomonic for GBM).
If a tumor is IDH wildtype, it is automatically GBM if one of the following is present:
- TERT promoter mutation
- EGFR amplification
- combined gain of entire chromosome 7 and loss of entire chromosome 10 [+7/-10]
- necrosis
- microvascular proliferation
What are molecular biomarkers in CNS cancers
CDKN2A/B: homozygous deletion in IDH-mutant astrocytoma’s
GBM: automatically GBM if: TERT promoter mutation, EGFR amplification, +7/-10 copy number change
Glioma and GBM systemic therapies:
LGG: adjuvant PCV x 6
AO: PCV x 6
AA: RT -> Adjuvant TMZ 150mg/m2 d1-5 q28d cycles x 12 cycles
GBM: CRT with concurrent TMZ 75mg/m2 EVERY DAY -> adjuvant TMZ 150mg/m2 d1-5 q28d cycles x 6 cycles
Toxicity of WBRT/GBM treatment
ACUTE:
Alopecia (2nd to 3rd week)
Dermatitis
Fatigue
Transient worsening of symp d/t edema (esp 1st 2 wks)
N/V: esp brainstem
Otitis externa
LATE:
Alopecia (hair regrowth, if ever, 3-6m)
Telangectasias
RT necrosis
Diffuse leukoencephalopathy
Cerebral atrophy
Hearing loss
Retinopathy, cataract, visual change
Endocrine abnormality
Vasculopathy
Neurocog: decr new learning ability, short term memory, problem solving skills
2nd malignancy
Pituitary adenoma management
1) management
2) LC with RT
3) what labs to monitor for
GTR -> OBS
If medically inoperable or recurrence not amendable to sx: 50/25 (CTV 0mm duh)
LC: 90%
Most common deficiency after RT: GH: monitor with IGF-1.
Others: TSH, prolactin, cortisol, if a female with amenorrhea then LH and FSH
bitemporal hemaniopsia caused by
If lesion in left occipital what visual field deficit?
1) chiasm
2): right homonymous hemianopsia (right visual field loss)
Hormones produced by pituitary:
1) anterior (6)
2) posterior (2)
1) LSH, FSH, TSH, ACTH, GH, prolactin
2) Oxytocin, ADH
What are the indications for adjuvant radiation in pituitary adenomas/indications for post-op RT
Pituitary:
Non-functional: GTR-> observe. If SRT -> consider XRT on progression (this is benign, do not want 2% risk of 2ndary malignancy, this can be a GBM and the patient can die)
Functional:
XRT if unresectable, medically inoperable.
- IF functional, not controlled by medical management and recurrent after multiple surgeries then do XRT
DOSE: always say 54/30 or 50/25 do not say SRS for these hehe but if you need to know it, it is 15/1 non functional, 20/1 for functional
What is a potentially fatal complication of macroadenoma if untreated
Pituitary apoplexy: due to acute ischemic infarct or hemhorrahge of the pituitary: causes bitemporal hemaniopsia, double vision, and pain
Differential diagnosis for GBM (not including glioma)
Benign: Infection/abscess, AVM –arteriovenous malformation, Foreign body – ie: bullet, Hemorrhage/blood Multiple sclerosis (demyelinating plaque, Radiation necrosis
Malignant: Mets, Ependymoma, Germinoma, Schwannoma (acoustic neuroma), Pituitary adenoma, Primary CNS lymphoma, Meningioma, Choroid Plexus Tumors, Germ Cell Tumors
NOTE: DDX rim enhancing lesion: MAGIC DR:
M: etastasis
A: abscess
G: GBM
I: infarct
C: contusion
D: demyelinating (MS)
R: radiaiton necrosis
What is PCV and what class of chemotherapies
Procarbazine: (alkylating agent)
CCNU: (aka lomustine): alkylating agent
Vincristine: vinca alkyloid
TMZ:also alkylating agent
Question about dilantin:
1) side effects of dilantin:
2) what is the point of a loading dose
What are side effects of dilantin
1) N/V, abdominal pain, liver dysfunction, skin reaction, gingival hypertrophy
2) Achieve therapeutic level more quickly- need to monitor serum pheny level
TMZ class and S/E
Alkylating agent! Thrombocytopenia, fatigue, nausea!!!!